A detailed history of Northeast Financial Consultants Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Northeast Financial Consultants Inc holds 75,745 shares of MRK stock, worth $7.3 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
75,745
Previous 75,586 0.21%
Holding current value
$7.3 Million
Previous $9.36 Million 8.08%
% of portfolio
0.38%
Previous 0.43%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$111.15 - $128.97 $17,672 - $20,506
159 Added 0.21%
75,745 $8.6 Million
Q2 2024

Aug 15, 2024

SELL
$123.8 - $132.96 $131,228 - $140,937
-1,060 Reduced 1.38%
75,586 $9.36 Million
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $122,865 - $143,165
1,085 Added 1.44%
76,646 $10.1 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $9,216 - $10,029
92 Added 0.12%
75,561 $8.24 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $35,003 - $38,872
340 Added 0.45%
75,469 $7.77 Million
Q2 2023

Aug 08, 2023

BUY
$108.61 - $118.38 $8,797 - $9,588
81 Added 0.11%
75,129 $8.67 Million
Q1 2023

May 15, 2023

BUY
$102.94 - $114.86 $8,544 - $9,533
83 Added 0.11%
75,048 $7.98 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $93,211 - $119,509
-1,066 Reduced 1.4%
74,965 $8.32 Million
Q3 2022

Nov 15, 2022

BUY
$84.53 - $94.96 $66,863 - $75,113
791 Added 1.05%
76,031 $6.55 Million
Q2 2022

Aug 12, 2022

SELL
$83.49 - $94.64 $183,344 - $207,829
-2,196 Reduced 2.84%
75,240 $6.86 Million
Q1 2022

May 12, 2022

BUY
$73.51 - $82.4 $176,276 - $197,595
2,398 Added 3.2%
77,436 $6.35 Million
Q4 2021

Feb 11, 2022

SELL
$72.28 - $90.54 $83,266 - $104,302
-1,152 Reduced 1.51%
75,038 $5.75 Million
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $2.85 Million - $3.14 Million
-39,800 Reduced 34.31%
76,190 $5.72 Million
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $38,811 - $42,929
552 Added 0.48%
115,990 $9.02 Million
Q1 2021

May 13, 2021

SELL
$68.86 - $81.11 $43,932 - $51,748
-638 Reduced 0.55%
115,438 $8.9 Million
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $46,076 - $51,135
642 Added 0.56%
116,076 $9.5 Million
Q3 2020

Oct 29, 2020

BUY
$73.18 - $82.95 $24,149 - $27,373
330 Added 0.29%
115,434 $9.58 Million
Q2 2020

Jul 30, 2020

BUY
$70.42 - $80.13 $6,126 - $6,971
87 Added 0.08%
115,104 $8.9 Million
Q1 2020

May 13, 2020

BUY
$63.36 - $87.82 $4,942 - $6,849
78 Added 0.07%
115,017 $8.85 Million
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $120,171 - $135,599
-1,549 Reduced 1.33%
114,939 $10.5 Million
Q3 2019

Nov 13, 2019

BUY
$76.08 - $82.93 $95,480 - $104,077
1,255 Added 1.09%
116,488 $9.81 Million
Q2 2019

Aug 09, 2019

BUY
$69.84 - $81.59 $5,307 - $6,200
76 Added 0.07%
115,233 $9.66 Million
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $35,416 - $40,394
-509 Reduced 0.44%
115,157 $9.58 Million
Q4 2018

Feb 12, 2019

BUY
$65.24 - $75.71 $7.35 Million - $8.53 Million
112,657 Added 3744.0%
115,666 $8.84 Million
Q3 2018

Nov 08, 2018

BUY
$57.69 - $67.84 $173,589 - $204,130
3,009 New
3,009 $213,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $244B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Northeast Financial Consultants Inc Portfolio

Follow Northeast Financial Consultants Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.